CLINICAL_TRIALS
trial_result
· 2026-04-02
Clinical Trial Update: Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia [NA]
Summary
A clinical trial evaluating low-intensity focused ultrasound neuromodulation of the mediodorsal thalamus for treatment-resistant schizophrenia is currently susp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: Treatment-resistant Schizophrenia | NA | Status: SUSPENDED